61040-22-0

Basic information

• Product Name: L-Alanine, N-[(1,1-diMethylethoxy)carbonyl]-3-[[(phenylMethoxy)carbonyl]aMino]-, Methyl ester
• Synonyms: L-Alanine, N-[(1,1-diMethylethoxy)carbonyl]-3-[[(phenylMethoxy)carbonyl]aMino]-, Methyl ester
• CAS NO: 61040-22-0
• Molecular Formula: C₁₇H₂₄N₂O₆
• Molecular Weight: 352.38226
• Mol File: 61040-22-0.mol
• Article Data: 16

Chemical Properties

• Appearance: /
• CAS DataBase Reference: L-Alanine, N-[(1,1-diMethylethoxy)carbonyl]-3-[[(phenylMethoxy)carbonyl]aMino]-, Methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: L-Alanine, N-[(1,1-diMethylethoxy)carbonyl]-3-[[(phenylMethoxy)carbonyl]aMino]-, Methyl ester(61040-22-0)
• EPA Substance Registry System: L-Alanine, N-[(1,1-diMethylethoxy)carbonyl]-3-[[(phenylMethoxy)carbonyl]aMino]-, Methyl ester(61040-22-0)

Safety Data

• Hazardous Substances Data: 61040-22-0(Hazardous Substances Data)

Upstream product

• 186581-53-3 diazomethane 
• 7536-55-2 N-tert-butyloxycarbonylasparagine 
• 501-53-1 benzyl chloroformate 
• 1070-19-5 N-(tert-butyloxycarbonyl) azide 
• 71749-02-5 N^β-Z-Dap-OMe*HCl 
• 76387-70-7 (S)-3-amino-2-tert-butoxycarbonylaminopropionic acid 
• 365441-84-5 [furan-2-yl-(toluene-4-sulfonyl)-methyl]-carbamic acid tert-butyl ester 
• 1235352-41-6 methyl (2S)-2-{[(tert-butoxy)carbonyl]amino}-3-nitropropanoate 
• 65710-57-8 3-{[(benzyloxy)carbonyl]amino}-N-(tert-butoxycarbonyl)-L-alanine 
• 74-88-4 methyl iodide 
• 67-56-1 methanol 
• 65621-26-3 (S)-N,N'-dicarbobenzyloxy-2,3-diaminopropanoic acid 
• 97651-96-2 (S)-methyl 2-[(tert-butoxycarbonyl)amino]-3-(4-phenyl-1H-1,2,3-triazol-1-yl)propanoate 
• 2766-43-0 N-tert-butyloxycarbonyl-L-serine methyl ester 

Downstream Products

• 1269759-73-0 N-(2-Boc-aminoethyl)-N-(3-Cbz-amino-D-alanyl)methyl ester 
• 1269759-75-2 N-(2-Boc-aminoethyl)-N-(chloroacetyl)-N-(3-Cbz-amino-Dalanyl)methyl ester 
• 1269759-77-4 N-(2-Boc-aminoethyl)-N-(thymine-1-acetyl)-N-(3-Cbz-amino-D-alanyl)methyl ester 
• 1269759-79-6 N-(2-Boc-aminoethyl)-N-(thymine-1-ylacetyl)-N-(3-Cbz-amino)-D-alanine 
• 1269759-74-1 N-(2-Boc-aminoethyl)-N-(chloroacetyl)-N-(3-Cbz-amino-L-alanyl)methyl ester 
• 1269759-76-3 N-(2-Boc-aminoethyl)-N-(thymine-1-acetyl)-N-(3-Cbz-amino-L-alanyl)methyl ester 
• 1269759-78-5 N-(2-Boc-aminoethyl)-N-(thymine-1-ylacetyl)-N-(3-Cbz-amino)-L-alanine 
• 721927-81-7 benzyl tert-butyl [(2S)-3-hydroxypropan-1,2-diyl]biscarbamate 
• 1269759-80-9 (S)-benzyl tert-butyl (3-azidopropane-1,2-diyl)dicarbamate 
• 1269759-81-0 (R)-benzyl tert-butyl (3-aminopropane-1,2-diyl)dicarbamate 
• 1269759-82-1 C₂₀H₃₁N₃O₆ 
• 1269759-83-2 C₂₂H₃₂ClN₃O₇ 
• 1269759-84-3 C₂₇H₃₇N₅O₉ 
• 1269759-85-4 C₂₅H₃₃N₅O₉ 

Relevant articles and documents

LINKING AMINO ACID SEQUENCES, MANUFACTURING METHOD THEREOF, AND USE THEREOF

This invention provides compositions comprising linked amino acid sequences, pharmaceutical compositions comprising linked amino acid sequences, and methods of making thereof. This invention also provides methods of delivering said compositions to subjects and methods of treating various disorders and diseases using the said compositions.

A short, rigid linker between pyrene and guanidiniocarbonyl-pyrrole induced a new set of spectroscopic responses to the ds-DNA secondary structure

A novel pyrene-guanidiniocarbonyl-pyrrole dye, characterised by a short, rigid linker between the two chromophores, interacts strongly with ds-DNA but only negligibly with ds-RNA. Under neutral conditions the dye shows strong selectivity toward AT-DNA (with respect to GC-DNA). Binding is accompanied by a specific ICD band at 350 nm and fluorescence quenching for all DNAs/RNAs studied. At pH 5 the affinity of the dye is reversed, now favouring GC-DNA over AT-DNA. A strong emission increase for AT-DNA is observed but with quenching for GC-DNA.

2-PYRIDYL CARBOXAMIDE-CONTAINING SPLEEN TYROSINE KINASE (SYK) INHIBITORS

The invention provides certain 2-pyridyl carboxamide-containing compounds of the Formula (I) or pharmaceutically acceptable salts thereof, wherein A and B are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk) kinase.